Rogalski T M, Bullerjahn A M, Riddle D L
Division of Biological Sciences, University of Missouri, Columbia 65211.
Genetics. 1988 Oct;120(2):409-22. doi: 10.1093/genetics/120.2.409.
Mutants of Caenorhabditis elegans resistant to alpha-amanitin have been isolated at a frequency of about 1.6 x 10(-6) after EMS mutagenesis of the wild-type strain, N2. Four new dominant resistance mutations have been studied genetically. Three are alleles of a previously identified gene, ama-1 IV, encoding the largest subunit of RNA polymerase II. The fourth mutation defines a new gene, ama-2 V. Unlike the ama-1 alleles, the ama-2 mutation exhibits a recessive-lethal phenotype. Growth and reproduction of N2 was inhibited at a concentration of 10 micrograms/ml amanitin, whereas ama-2/+ animals were inhibited at 100 micrograms/ml, and 800 micrograms/ml was required to inhibit growth of ama-1/+ larvae. We have also determined that two reference strains used for genetic mapping, dpy-11(e224)V and sma-1(e30)V, are at least four-fold more sensitive to amanitin that the wild-type strain. Using an amanitin-resistant ama-1(m118) or ama-1(m322) strain as a parent, we have isolated amanitin-sensitive mutants that carry recessive-lethal ama-1 alleles. The frequency of EMS-induced lethal ama-1 mutations is approximately 1.7 x 10(-3), 1000-fold higher than the frequency of amanitin-resistance alleles. Nine of the lethal alleles are apparent null mutations, and they exhibit L1-lethal phenotypes at both 20 degrees and 25 degrees. Six alleles result in partial loss of RNA polymerase II function as determined by their sterile phenotypes at 20 degrees. All but one of these latter mutations exhibit a more severe phenotype at 25 degrees C. We have also selected seven EMS-induced revertants of three different ama-1 lethals. These revertants restore dominant resistance to amanitin. The selection for revertants also produced eight new dominant amanitin resistance alleles on the balancer chromosome, nT1.
在对野生型菌株N2进行EMS诱变后,已以约1.6×10⁻⁶的频率分离出对α-鹅膏菌素具有抗性的秀丽隐杆线虫突变体。对四个新的显性抗性突变进行了遗传学研究。其中三个是先前鉴定的基因ama-1 IV的等位基因,该基因编码RNA聚合酶II的最大亚基。第四个突变定义了一个新基因ama-2 V。与ama-1等位基因不同,ama-2突变表现出隐性致死表型。在10微克/毫升鹅膏菌素浓度下,N2的生长和繁殖受到抑制,而ama-2 / +动物在100微克/毫升时受到抑制,抑制ama-1 / +幼虫生长则需要800微克/毫升。我们还确定,用于基因定位的两个参考菌株dpy-11(e224)V和sma-1(e30)V对鹅膏菌素的敏感性至少是野生型菌株的四倍。以抗鹅膏菌素的ama-1(m118)或ama-1(m322)菌株作为亲本,我们分离出了携带隐性致死ama-1等位基因的对鹅膏菌素敏感的突变体。EMS诱导的致死性ama-1突变的频率约为1.7×10⁻³,比抗鹅膏菌素等位基因的频率高1000倍。九个致死等位基因明显是无效突变,它们在20℃和25℃时均表现出L1致死表型。六个等位基因导致RNA聚合酶II功能部分丧失,这是由它们在20℃时的不育表型确定的。除一个突变外,所有这些突变在25℃时表现出更严重的表型。我们还选择了三个不同ama-1致死突变的七个EMS诱导的回复突变体。这些回复突变体恢复了对鹅膏菌素的显性抗性。对回复突变体的选择还在平衡染色体nT1上产生了八个新的显性鹅膏菌素抗性等位基因。